Journal
TRENDS IN PARASITOLOGY
Volume 34, Issue 1, Pages 80-90Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.pt.2017.09.003
Keywords
-
Categories
Funding
- Intramural NIH HHS [ZIA AI000512-29] Funding Source: Medline
Ask authors/readers for more resources
Filarial infections of humans cause some of the most important neglected tropical diseases. The global efforts for eliminating filarial infections by mass drug administration programs may require additional tools (safe macrofilaricidal drugs, vaccines, and diagnostic biomarkers). The accurate and sensitive detection of viable parasites is essential for diagnosis and for surveillance programs. Current community-wide treatment modalities do not kill the adult filarial worms effectively; hence, there is a need to identify and develop safe macrofilaricidal drugs. High-throughput sequencing, mass spectroscopy methods and advances in computational biology have greatly accelerated the discovery process. Here, we describe post-genomic developments toward the identification of diagnostic biomarkers and drug targets for the filarial infection of humans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available